Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.
Afqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration ...
Afqlir is indicated to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD) ...
Evaluation of luciferase and prefusion-stability F protein from respiratory syncytial virus mRNA/LNPs in pre-clinical models using jet delivery compared to needle and syringe ... in mRNA technologies ...
A closed aquatic ecosystem established on China space station proved to be successful as four zebrafish kept in it completed their life stages from g ...
The new line, with its capability to handle multiple syringe sizes (1 ml, 2.25 ml ... at the Gerontological Society of America Annual Scientific Meeting 2024 Epirium Bio, Inc. (Epirium), a ...
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
Hosted on MSN2d
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call TranscriptThis will include considerations such as scientific rationale and reasons to believe our ... also included our product ...
Health authorities say they are continuing to manage the shortage and supply of IV fluids as a priority. Doctors are fighting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback